Routine Check-Up Saved Woman’s Life After Unexpected Cancer Diagnosis | Marie Keating Foundation

A routine health check, prompted simply by its affordability, led to a life-altering discovery for Anne O’Carroll: triple-negative breast cancer. The story underscores the potential value of proactive health screening, even for those feeling perfectly well, and highlights the nuances of this aggressive form of the disease.

The Unexpected Finding

In December 2012, O’Carroll, then 46, opted for a full body check-up costing €50. Having recently reduced her health insurance coverage, she found the check-up offered a comprehensive assessment at a reasonable price. “I felt as fit as a trout and had no concerns whatsoever,” she recalls. During a breast scan, a radiographer detected a lump, described as “the size of a considerable grape,” under her right nipple. Further testing confirmed a diagnosis of triple-negative breast cancer – a particularly fast-acting type requiring immediate intervention.

Triple-negative breast cancer (TNBC) is defined by the absence of estrogen receptors, progesterone receptors, and high levels of HER2 protein on cancer cells. This lack of receptors means that common hormone therapies and HER2-targeted treatments are ineffective, leaving chemotherapy as the primary systemic treatment option. According to consultant medical oncologist Prof Janice Walshe from St Vincent’s University Hospital, Dublin, around one in eight breast cancers in Ireland are triple negative. The Marie Keating Foundation is currently raising awareness of TNBC, emphasizing the importance of seeking medical advice for any breast changes.

Treatment and Recovery

O’Carroll’s treatment plan was intensive, beginning with chemotherapy in early 2013. Her oncologist advised her to dedicate the entire year to her medical care, acknowledging the potential for disruptions due to treatment side effects. The chemotherapy was described as “absolutely brutal,” significantly impacting her physical abilities and overall well-being. This was followed by a lumpectomy and radiotherapy. The treatment too induced a chemical menopause, bringing with it a host of associated symptoms.

“It knocked me for six,” O’Carroll stated. She emphasizes the importance of self-care during treatment, acknowledging that recovery is a long and gradual process. She advises those diagnosed with cancer to prioritize their well-being, allowing themselves rest when needed and embracing small pleasures. She also suggests proactively communicating with loved ones about limitations in availability for social interaction, offering a message or email to manage expectations.

Who is at Increased Risk?

While TNBC can present with the same symptoms as other breast cancers – a lump or thickening, changes in size or shape, skin changes, nipple discharge, or changes in nipple position – it disproportionately affects certain populations. Prof. Walshe notes that younger women (under 40), Black women, and those with inherited BRCA1 gene mutations are at higher risk. The National Cancer Institute provides further information on risk factors and genetic testing for breast cancer.

O’Carroll herself noticed a subtle change prior to her diagnosis – a slight fullness on the right side of her bra, with one cup appearing fuller than the other. This seemingly minor observation proved to be a crucial early indicator. She stresses the importance of paying attention to any unusual changes and seeking medical advice promptly.

The Role of Early Detection

The case highlights the potential benefits of early detection, even in the absence of noticeable symptoms. O’Carroll’s doctor indicated that a delay in diagnosis could have led to the cancer spreading to other organs, significantly impacting her prognosis. This underscores the value of regular health screenings and self-awareness.

More than 3,700 women are diagnosed with breast cancer in Ireland each year. The Health Service Executive (HSE) provides comprehensive information on breast cancer screening programs and resources for patients and their families.

Advances in Treatment: Immunotherapy

While chemotherapy remains the cornerstone of TNBC treatment, recent advancements offer new hope. Immunotherapy has emerged as a significant development in managing this aggressive disease. Treatment often involves initiating chemotherapy, potentially with immunotherapy, before surgery. Surgical options include lumpectomy or mastectomy, often accompanied by lymph node removal to assess for cancer spread. Radiotherapy is frequently recommended following surgery.

The effectiveness of immunotherapy in TNBC stems from its ability to harness the body’s own immune system to fight cancer cells. However, it’s vital to note that immunotherapy is not effective for all patients with TNBC, and ongoing research is focused on identifying biomarkers that can predict treatment response.

Looking Ahead: Surveillance and Research

Continued surveillance and research are crucial for improving outcomes in TNBC. Ongoing clinical trials are investigating new treatment strategies, including targeted therapies and novel immunotherapeutic approaches. Researchers are also working to better understand the genetic and molecular characteristics of TNBC, with the goal of developing personalized treatment plans. The focus remains on improving early detection, refining treatment protocols, and enhancing the quality of life for individuals affected by this challenging disease.